Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations

MLA

Heather E. desJardins-Park, et al. “Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-Dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations.” Plastic and Reconstructive Surgery Global Open, vol. 8, May 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b7cb0e53ccbe3c014ed45693efb69ade&authtype=sso&custid=ns315887.

APA

Heather E. desJardins-Park, Shamik Mascharak, Michelle Griffin, Nestor M. Deleon Diaz, Lui Cui, Michael T. Longaker, Geoffrey C. Gurtner, Bryan Duoto, Howard Y. Chang, Mimi R. Borrelli, Tristan Lerbs, Michael Januszyk, Marc Gastou, Derrick C. Wan, Sandeep Adem, Gerlinde Wernig, Hermann P. Lorenz, Julia T. Garcia, & Alexandra L. Moore. (2020). Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations. Plastic and Reconstructive Surgery Global Open, 8.

Chicago

Heather E. desJardins-Park, Shamik Mascharak, Michelle Griffin, Nestor M. Deleon Diaz, Lui Cui, Michael T. Longaker, Geoffrey C. Gurtner, et al. 2020. “Abstract 186: CD36 Antagonism Minimizes Skin Scarring By Inhibiting JUN-Dependent Fibrotic Pathways Within Fibrogenic Fibroblast Subpopulations.” Plastic and Reconstructive Surgery Global Open 8 (May). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b7cb0e53ccbe3c014ed45693efb69ade&authtype=sso&custid=ns315887.